Compound anti-hypertensive tablets (No.0) for primary hypertension:a systematic review

WU Yi-qun,HE Liu,SONG Yan,ZHANG Yi,HU Yong-hua

2009-01-01

Abstract:Objective To systematically review the efficacy and safety of Compound Anti-Hypertensive Tablets(No.0) for primary hypertension.Methods The following databases were searched from their inception: Cochrane Library,MEDLINE,OVID,PubMed Central,CBMDISC,CNKI,VIP information and Wanfang Data Info Site.Experts were contracted for unpublished data.Two independent investigators extracted the detailed data and assessed study quality using pre-established criteria for different kinds of studies.Meta analysis was performed using Rev Man 4.2 software.Random or fixed effect models were used according to degree of heterogeneity.Sensitivity analyses and subgroup analyses were performed too.Results 649 related articles were collected following the searching strategies and 19 studies were eligible for inclusion.1.As to the efficacy,there was no statistical significant difference between Compound Anti-Hypertensive Tablets(No.0) and other anti-hypertensive drugs(RR=1.02,95% CI 0.98 to 1.05,P=0.39).2.For the safety,there was also no statistical significant difference between the research drug and the control(RD=-0.01,95% CI-0.03 to 0.02,P=0.65).Conclusions Based on current evidence,Compound Anti-Hypertensive Tablets(No.0) appears to have the same effect as other anti-hypertensive drugs without having more adverse events.However,multi-center large-scale randomized conrolled trials of higher quality are needed to to enrich current evidence.